Federated Hermes, Inc. Decibel Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

  • $43.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$1.85 - $4.21 $9,250 - $21,050
5,000 Added 33.33%
20,000 $84,000
Q3 2021

Nov 15, 2021
BUY
$6.6 - $9.04 $33,000 - $45,199
5,000 Added 50.0%
15,000 $116,000
Q2 2021

Aug 16, 2021
SELL
$6.39 - $11.51 $63,900 - $115,100
-10,000 Reduced 50.0%
10,000 $86,000
Q1 2021

May 13, 2021
BUY
$10.56 - $19.9 $211,200 - $398,000
20,000 New
20,000 $228,000

About Decibel Therapeutics, Inc.

DBTX Quotes by TradingView
  • Ticker DBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,964,500
  • Description
  • Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...
More about DBTX
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email